Sources | Names Used |
---|---|
CTRPv2 | crizotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | crizotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | HIST2H2AA3 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.02 |
mRNA | MAP3K1 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
mRNA | GRIK2 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
mRNA | MGEA5 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.02 |
mRNA | SOX30 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.02 |
mRNA | PECR | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
mRNA | ARL6IP6 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |
mRNA | NCK2 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
mRNA | ZFP1 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
mRNA | SOCS2 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |